Nisin resistance in Gram-positive bacteria and approaches to circumvent resistance for successful therapeutic use.


Journal

Critical reviews in microbiology
ISSN: 1549-7828
Titre abrégé: Crit Rev Microbiol
Pays: England
ID NLM: 8914274

Informations de publication

Date de publication:
May 2021
Historique:
pubmed: 11 3 2021
medline: 14 5 2021
entrez: 10 3 2021
Statut: ppublish

Résumé

Antibiotic resistance among bacterial pathogens is one of the most worrying problems in health systems today. To solve this problem, bacteriocins from lactic acid bacteria, especially nisin, have been proposed as an alternative for controlling multidrug-resistant bacteria. Bacteriocins are antimicrobial peptides that have activity mainly against Gram-positive strains. Nisin is one of the most studied bacteriocins and is already approved for use in food preservation. Nisin is still not approved for human clinical use, but many

Identifiants

pubmed: 33689548
doi: 10.1080/1040841X.2021.1893264
doi:

Substances chimiques

Anti-Bacterial Agents 0
Nisin 1414-45-5

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

376-385

Auteurs

Ana Andréa Teixeira Barbosa (AAT)

Programa de Pós-Graduação em Biologia Parasitária, Universidade Federal de Sergipe, São Cristóvão, Brasil.

Marcelo Rodrigues de Melo (MR)

Universidade Estadual de Londrina, Londrina, Brazil.

César Matos Ribeiro da Silva (CMR)

Programa de Pós-Graduação em Biologia Parasitária, Universidade Federal de Sergipe, São Cristóvão, Brasil.

Sona Jain (S)

Programa de Pós-Graduação em Biotecnologia Industrial, Universidade Tiradentes, Sergipe, Brasil.

Silvio Santana Dolabella (SS)

Programa de Pós-Graduação em Biologia Parasitária, Universidade Federal de Sergipe, São Cristóvão, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH